In global health, is ‘disruption’ a good thing?
Friday, June 6, 2014
What makes for a sound investment in global health? The answer is more complicated than you might think.
Some solutions — a new medication, technology or delivery mechanism, for instance — can have huge potential to improve health outcomes but at the same time, also be difficult to incorporate into the health systems already found within a country or a community. More systemic changes lack the headline-grabbing punch that the next wonder drug tends to invite.
Development practitioners must pay attention to a range of complex factors when they explore cost-effective and high-impact health solutions, and international organizations can play a role in bringing those pieces together, Amie Batson, chief strategy officer at PATH, told Devex recently.
In the below video interview that is part of our joint Best Buys in Global Health campaign withPSI, the global health NGO, Batson discusses what it takes to make the case for sound investments in health, and the tradeoffs different options often present.